Basic Information
Instituto de Medicina Genomica (Imegen) is a biopharmaceutical company specializing in genetic analysis services and products. The company's mission is to improve people's health and quality of life through diagnostic, prognostic, and preventive genetic services. Its goal is to become a global reference in human genetics by offering one of the widest portfolios of genetic analyses. It encourages partnerships with domestic and international companies and research teams and continuously invests in R&D to enhance its competitiveness. Instituto de Medicina Genomica was founded in January 2009 and is headquartered in Paterna, Spain.